BioProcess360 Partners

BioProcess360 Partners provides specialized capital and hands-on operational expertise to innovative bioprocessing technologies. The firm offers strategic guidance across R&D, manufacturing, and commercialization, accelerating the scaling of promising solutions. This collaborative approach leverages deep industry knowledge to navigate growth challenges.

Founded by Chris Major and Brad Beatty, recognizing a need for integrated financial and operational bioprocessing support. Major, a serial entrepreneur, brings two decades of experience from Purolite Bioprocessing. Beatty, as Chief Investment Officer, contributes expertise in investment strategy and scaling growth-stage businesses.

BioProcess360 Partners targets companies developing bioprocessing solutions, assisting ventures from concept through commercialization, needing capital for scaling. Their vision centers on advancing bioprocessing technologies to improve patient outcomes. They empower portfolio companies to achieve sustained market impact and foster innovation.